Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 865

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 865
---
 Company has included the impact of this provision, which results in a deferred tax asset of approximately $4.2 million as of December 31, 2024 and approximately $4.4 million as of December 31, 2023. On August 16, 2022, the Inflation Reduction Act (“IRA”) was enacted into US law. Effective for tax years beginning after December 31, 2022, the IRA imposes a 15% corporate minimum tax, a 1% excise tax on share repurchases, and creates and extends certain tax-relatedenergy incentives. Management does not expect the tax-relatedprovisions of the IRA to have a material impact on the Company’s consolidated financial statements. Unrecognized Tax Benefits The unrecognized tax benefits, if recognized, would not have an impact on the Company’s effective tax rate assuming the Company continues to maintain a full valuation allowance position. As of December 31, 2024, no significant increases or decreases are expected to the Company’s uncertain tax positions within the next twelve months.

|                                                                |     | Years Ended    
 December 31,   
 2024           
 (in thousands) |       |     | 2023 |       |
|:---------------------------------------------------------------|:----|:---------------|------:|:----|:-----|------:|
| Beginning balance of unrecognized tax benefits                 |     | $              | 1,000 |     | $    |   828 |
| Gross increases based on tax positions related to current year |     |                |    77 |     |      |   172 |
| Ending balance of unrecognized tax benefits                    |     | $              | 1,077 |     | $    | 1,000 |

Interest and penalties related to the Company’s unrecognized tax benefits accrued as of December 31, 2024 were not material. The Company does not expect its uncertain tax positions to have material impact on its consolidated financial statements within the next twelve months. All of the unrecognized tax benefits as of December 31, 2024 are accounted for as a reduction in the Company’s deferred tax assets. The Company files federal and state income tax returns subject to varying statutes of limitations. Due to net operating loss carryforwards, the Company’s income tax returns generally remain subject to examination by federal and state tax authorities. 13. Net Loss Per Share The following table summarizes the computation of basic and diluted net loss per share:

|                                                                  |     | Years Ended December 31, |         |   |     |